| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
36,010,000 |
| Market
Cap: |
527.19(M) |
| Last
Volume: |
129,261 |
Avg
Vol: |
128,904 |
| 52
Week Range: |
$9.69 - $21.36 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Orthofix Medical is a medical device company. Co.'s Global Spine segment provides implantable medical devices, biologics, and other regenerative solutions. This segment's product categories include: Bone Growth Therapies, which manufactures, distributes, and provides support services for bone growth stimulation devices; Spinal Implants, which designs, develops and markets a portfolio of motion preservation and fixation implant products; and Biologics, which provides a portfolio of products and tissue forms. Co.'s Global Orthopedics segment provides products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,500 |
7,500 |
| Total Buy Value |
$0 |
$0 |
$101,025 |
$101,025 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
8,243 |
12,505 |
| Total Sell Value |
$0 |
$0 |
$156,617 |
$232,268 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
3 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sainz Maria |
Director |
– • – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,950 |
24,778 |
|
- |
|
| Faulstick Luke T |
Director |
– • – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,950 |
8,950 |
|
- |
|
| Jordan Guy J |
Director |
– • – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,950 |
19,720 |
|
- |
|
| Marks Lilly |
Director |
– • – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,950 |
10,450 |
|
- |
|
| Matricaria Ronald A |
Director |
– • – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,200 |
82,667 |
|
- |
|
| Sainz Maria |
Director |
– • – |
2016-06-10 |
4 |
S |
$46.33 |
$192,590 |
D/D |
(4,157) |
20,828 |
|
- |
|
| Mason Brad |
CEO |
• – – |
2016-06-09 |
4 |
AS |
$46.00 |
$843,456 |
D/D |
(18,336) |
141,920 |
|
- |
|
| Mason Brad |
CEO |
• – – |
2016-06-09 |
4 |
OE |
$38.11 |
$762,200 |
D/D |
20,000 |
160,256 |
|
- |
|
| Niemann Bradley V. |
President Biostim |
• – – |
2016-06-08 |
4/A |
S |
$44.70 |
$152,069 |
D/D |
(3,402) |
28,275 |
|
- |
|
| Niemann Bradley V. |
President Biostim |
• – – |
2016-06-08 |
4/A |
OE |
$36.25 |
$100,594 |
D/D |
2,775 |
31,677 |
|
- |
|
| Niemann Bradley V. |
President Biostim |
• – – |
2016-06-08 |
4 |
S |
$44.70 |
$152,069 |
D/D |
(3,402) |
25,500 |
|
- |
|
| Goodwin Robert Allen Ii |
President Biologics |
• – – |
2016-05-20 |
4 |
S |
$44.00 |
$580,228 |
D/D |
(13,187) |
27,920 |
|
- |
|
| Goodwin Robert Allen Ii |
President Biologics |
• – – |
2016-05-20 |
4 |
OE |
$38.11 |
$515,763 |
D/D |
13,187 |
41,107 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2016-04-18 |
4 |
AS |
$44.00 |
$1,265,000 |
D/D |
(28,750) |
38,774 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2016-04-18 |
4 |
OE |
$21.78 |
$690,775 |
D/D |
28,750 |
67,524 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2016-04-14 |
4 |
AS |
$42.00 |
$2,193,324 |
D/D |
(52,222) |
38,774 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2016-04-14 |
4 |
OE |
$38.11 |
$1,905,500 |
D/D |
50,000 |
90,996 |
|
- |
|
| Niemann Bradley V. |
President BiostimOfficer |
• – – |
2016-03-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,902 |
|
- |
|
| Goodwin Robert Allen Ii |
President BiologicsOfficer |
• – – |
2016-03-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
27,920 |
|
- |
|
| Fujikawa Raymond |
President Spine FixationOffice |
• – – |
2016-03-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,367 |
|
- |
|
| Paolucci Michael E |
Director |
– • – |
2016-03-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| Finegan Michael |
Chief Strategy Officer |
• – – |
2015-11-11 |
4 |
S |
$42.00 |
$593,880 |
D/D |
(14,140) |
58,252 |
|
- |
|
| Mason Brad |
CEO |
• – – |
2015-11-06 |
4 |
S |
$40.28 |
$609,779 |
D/D |
(15,018) |
140,256 |
|
- |
|
| Schumm Jeffrey |
Chief Administrative Officer |
• – – |
2015-11-06 |
4 |
S |
$40.25 |
$610,022 |
D/D |
(15,000) |
68,882 |
|
- |
|
| Marks Lilly |
Director |
– • – |
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
6,500 |
|
- |
|
697 Records found
|
|
Page 13 of 28 |
|
|
0.15 (1.04%) 
